Literature DB >> 10337356

Risk factors for stroke and primary prevention of stroke in atrial fibrillation.

A Laupacis1, D Singer, A Jacobsen, M Dunn, J Dalen, G Albers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10337356     DOI： 10.1023/a:1008819101803

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  26 in total

1.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.

Authors:  Daniel E Singer; Robert A Hughes; Daryl R Gress; Mary A Sheehan; Lynn B Oertel; Sue Ward Maraventano; Dyan Ryan Blewett; Bernard Rosner; J Philip Kistler
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

2.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

3.  The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.

Authors: 
Journal:  Arch Intern Med       Date:  1997-06-09

4.  Stroke in thyrotoxicosis with atrial fibrillation.

Authors:  P Petersen; J M Hansen
Journal:  Stroke       Date:  1988-01       Impact factor: 7.914

5.  Thyrotoxicosis, atrial fibrillation, and embolism, revisited.

Authors:  C F Presti; R G Hart
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

6.  Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

Authors:  C Morocutti; G Amabile; F Fattapposta; A Nicolosi; S Matteoli; M Trappolini; G Cataldo; G Milanesi; M Lavezzari; F Pamparana; S Coccheri
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

7.  Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

8.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

9.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

10.  Atrial fibrillation and arterial embolism in hyperthyroidism.

Authors:  D M Hurley; A N Hunter; M J Hewett; J R Stockigt
Journal:  Aust N Z J Med       Date:  1981-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.